The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal
Nutrients · 2026
DOI: 10.3390/nu18091472 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2026. Verfasst von Stefan Pilz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, Vitamin D Deficiency, Practice Guidelines as Topic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: An Endocrine Society Clinical Practice Guideline on vitamin D was published in 2024. Its main objective was the use of vitamin D to lower the risk of disease in individuals without established indications for vitamin D treatment or 25-hydroxavitamin D (25(OH)D) testing. The methodology followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) and the Evidence-to-Decision (EtD) framework. Evidence from randomized controlled trials (RCTs) retrieved by a systematic review was prioritized to inform this guideline. It was concluded that vitamin D supplementation reduces rickets and respiratory tract infections in children, mortality in individuals aged 75 years or older, pregnancy complications (outcomes), and progression of prediabetes to diabetes mellitus. Consequently, empiric vitamin D supplementation was recommended for individuals aged 1 to 18 years and ≥75 years, pregnant women, and individuals with prediabetes. Empiric vitamin D supplementation is defined as a vitamin D intake that exceeds the Dietary Reference Intakes (DRIs) and is implemented without 25(OH)D testing.
Methods
This article provides a comprehensive guideline summary and critical appraisal based on a narrative review on scientific publications regarding that guideline.
Results
Several publications discussed the 2024 Endocrine Society Clinical Practice Guideline on vitamin D. The main criticisms and discussion relate to unclear vitamin D dosages, guideline applicability to certain populations including controversy with previous vitamin D guidelines, and the implications of 25(OH)D testing.
Conclusions
The 2024 Endocrine Society Clinical Practice Guideline on vitamin D followed a rigorous methodological approach with high quality standards but it leaves many open questions and uncertainties warranting clarification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
- Department of Clinical Biochemistry, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
ORCID-Profile: Stefan Pilz, Pawel Pludowski, Uwe Riedmann
Zitieren
APA
Pilz, S., Pludowski, P., Kraus, D. A., Schmitt, L., & Riedmann, U. (2026). The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal. Nutrients. https://doi.org/10.3390/nu18091472
Vancouver
Pilz S, Pludowski P, Kraus DA, Schmitt L, Riedmann U. The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal. Nutrients. 2026. doi:10.3390/nu18091472
BibTeX
@article{Pilz2026,
author = {Pilz, Stefan and Pludowski, Pawel and Kraus, Daniel Arian and Schmitt, Lisa and Riedmann, Uwe},
title = {The 2024 Endocrine Society Guideline on Vitamin D: Comprehensive Summary and Critical Appraisal},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18091472}
}
EUVIMED